Mortality in COVID-19 patients with renal failure and need for dialysis. An evaluative review

Authors

DOI:

https://doi.org/10.20453/rmh.v35i3.5008

Keywords:

Kidney failure, COVID-19, mortality

Abstract

Objectives: To compare mortality in patients with COVID-19 and renal failure and need for hemodialysis from a general hospital in Lima, Peru and data from the world literature, and according to geographic areas in the world. Methods: Secondary research: evaluative review. PubMed was the database used for the bibliographic search. The keywords “renal failure”, “COVID 19” and “mortality” were used and the filters meta-analysis and systematic reviews. Thirteen articles were included. Results: The frequency of acute renal failure (AKI) and COVID-19 ranged between 8.4 and 26% and in Lima, Peru it was 22.6%; the hemodialysis (HD) rates in patients with COVID-19 was 2.97%, continuous renal replacement therapy (CRRT) was reported in AKI: Asia 1.4%, Europe 5.7% and North America 4.0% and in Lima, Peru 44.1% had CKD V on HD and 12.9% received HD for the first time (ARF 9.7% and CKD 3.2%); the OR for mortality in patients with COVID-19 and AKI ranged from 11.05 to 23.9 and mortality in patients with COVID-19 and ARF was in Asia 33.3%, Europe 29.4%, North America 7.4% and in Lima, Peru 81% (66.7% without HD and 100% with HD); in Lima, Peru, 33.3% had CKD, with an overall mortality of 23.7% (15.5% without HD and 100% with HD), and 44.1% had CKD V on HD with a mortality of 16.3%. Conclusion: Mortality in patients with COVID-19 and acute kidney failure and hemodialysis in Lima, Peru was higher compared to data in the world literature.

Downloads

Download data is not yet available.

Author Biographies

Victor Hugo Meneses-Liendo, Hospital Nacional Edgardo Rebagliati Martins. EsSALUD. Lima, Perú

             

Ernesto Valencia Valz, 2 Centro Médico Naval “Cirujano Mayor Santiago Távara”. Callao, Perú.

                    

References

Carlson N, Nelveg-Kristensen KE, Freese Ballegaard E, Feldt-Rasmussen B, Hornum M, Kamper AL, et al. Increased vulnerability to COVID-19 in chronic kidney disease. J Intern Med. 2021 Jul;290(1):166-178. doi: 10.1111/joim.13239. Epub 2021 Feb 10.

ERA-EDTA Council; ERACODA Working Group. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant. 2021 Jan 1;36(1):87-94. doi: 10.1093/ndt/gfaa314.

Wang F, Suo XG, Wang C, Wang JN, He XY, Wang FC, et al. Highly pathogenic coronaviruses, and the kidney. Biomed Pharmacother. 2022 Dec; 156:113807. doi: 10.1016/j.biopha.2022.113807. Epub 2022 Oct 11.

Menon T, Sharma R, Kataria S, Sardar S, Adhikari R, Tousif S, et al. The Association of Acute Kidney Injury with Disease Severity and Mortality in COVID-19: A Systematic Review and Meta-Analysis. Cureus. 2021 Mar 15;13(3): e13894. doi: 10.7759/cureus.13894.

Nadim MK, Forni LG, Mehta RL, Connor MJ Jr, Liu KD, Ostermann M, et al. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol. 2020 Dec;16(12):747-764. doi: 10.1038/s41581-020-00356-5. Epub 2020 Oct 15. Erratum in: Nat Rev Nephrol. 2020 Dec;16(12):765. doi: 10.1038/s41581-020-00372-5.

Husain-Syed F, Villa G, Wilhelm J, Samoni S, Matt U, Vadász I, et al. Renal markers for monitoring acute kidney injury transition to chronic kidney disease after COVID-19. Nephrol Dial Transplant. 2021 Nov 9;36(11):2143-2147. doi: 10.1093/ndt/gfab235.

Chan KW, Wong VT, Tang SCW. COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease. Am J Chin Med. 2020;48(3):737-762. doi: 10.1142/S0192415X20500378. Epub 2020 Mar 13.

Silver SA, Beaubien-Souligny W, Shah PS, Harel S, Blum D, Kishibe T, et al. The Prevalence of Acute Kidney Injury in Patients Hospitalized With COVID-19 Infection: A Systematic Review and Meta-analysis. Kidney Med. 2021 Jan-Feb;3(1):83-98. e1. doi: 10.1016/j.xkme.2020.11.008. Epub 2020 Dec 9.

Arikan H, Ozturk S, Tokgoz B, Dursun B, Seyahi N, Trabulus S, et al. Characteristics and outcomes of acute kidney injury in hospitalized COVID-19 patients: A multicenter study by the Turkish society of nephrology. PLoS One. 2021 Aug 10;16(8): e0256023. doi: 10.1371/journal.pone.0256023.

Fabrizi F, Alfieri CM, Cerutti R, Lunghi G, Messa P. COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis. Pathogens. 2020 Dec 15;9(12):1052. doi: 10.3390/pathogens9121052.

Kant S, Menez SP, Hanouneh M, Fine DM, Crews DC, Brennan DC, et al. The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation. BMC Nephrol. 2020 Oct 27;21(1):449. doi: 10.1186/s12882-020-02112-0.

Ng JH, Hirsch JS, Hazzan A, Wanchoo R, Shah HH, Malieckal DA, et al; Northwell Nephrology COVID-19 Research Consortium. Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury. Am J Kidney Dis. 2021 Feb;77(2):204-215.e1. doi: 10.1053/j.ajkd.2020.09.002. Epub 2020 Sep 19.

Chung EYM, Palmer SC, Natale P, Krishnan A, Cooper TE, Saglimbene VM, et al. Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2021 Dec;78(6):804-815. doi: 10.1053/j.ajkd.2021.07.003. Epub 2021 Aug 5.

Lin L, Wang X, Ren J, Sun Y, Yu R, Li K, et al. Risk factors and prognosis for COVID-19-induced acute kidney injury: a meta-analysis. BMJ Open. 2020 Nov 10;10(11): e042573. doi: 10.1136/bmjopen-2020-042573.

Meneses-Liendo V, Medina Chávez M, Gómez Lujan M, Cruzalegui Gómez C, Alarcón-Ruiz CA. Insuficiencia renal y hemodiálisis en pacientes hospitalizados con COVID-19 durante la primera ola en Lima, Perú. Acta Med Peru. 2021; 38(4):249-56. doi: 10.35663/amp.2021.384.216

Cheruiyot I, Henry B, Lippi G, et al. Acute Kidney Injury is Associated with Worse Prognosis In COVID-19 Patients: A Systematic Review and Meta-analysis. Acta Biomed. 2020 Sep;91(3): e2020029. DOI: 10.23750/abm. v91i3.10222.

Robbins-Juarez SY, Qian L, King KL, Stevens JS, Husain SA, Radhakrishnan J, et al. Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis. Kidney Int Rep [Internet]. 2020; Aug (8):1149–60. doi: 10.1016/j.ekir.2020.06.013

Wang B, Luo Q, Zhang W, Yu S, Cheng X, Wang L, et al. The Involvement of Chronic Kidney Disease and Acute Kidney Injury in Disease Severity and Mortality in Patients with COVID-19: A Meta-Analysis. Kidney Blood Press Res. 2021;46(1):17-30. doi: 10.1159/000512211. Epub 2020 Dec 22.

Alenezi FK, Almeshari MA, Mahida R, Bangash MN, Thickett DR, Patel JM. Incidence and risk factors of acute kidney injury in COVID-19 patients with and without acute respiratory distress syndrome (ARDS) during the first wave of COVID-19: a systematic review and Meta-Analysis. Ren Fail. 2021 Dec;43(1):1621-1633. doi: 10.1080/0886022X.2021.2011747.

Hansrivijit P, Qian C, Boonpheng B, Thongprayoon C, Vallabhajosyula S, Cheungpasitporn W, Ghahramani N. Incidence of acute kidney injury and its association with mortality in patients with COVID-19: a meta-analysis. J Investig Med. 2020 Oct;68(7):1261-1270. doi: 10.1136/jim-2020-001407. Epub 2020 Jul 12.

Ouyang L, Gong Y, Zhu Y, Gong J. Association of acute kidney injury with the severity and mortality of SARS-CoV-2 infection: A meta-analysis. Am J Emerg Med. 2021 May; 43:149-157. doi: 10.1016/j.ajem.2020.08.089. Epub 2020 Sep 2.

Shao M, Li X, Liu F, Tian T, Luo J, Yang Y. Acute kidney injury is associated with severe infection and fatality in patients with COVID-19: A systematic review and meta-analysis of 40 studies and 24,527 patients. Pharmacol Res. 2020 Nov; 161:105107. doi: 10.1016/j.phrs.2020.105107. Epub 2020 Jul 31.

NU. CEPAL. CELADE. Mortalidad por COVID-19: evidencias y escenarios. Serie Observatorio Demográfico de América Latina y el Caribe, 2020. Santiago: CEPAL. 2021. NU. CEPAL. CELADE. Mortalidad por COVID-19: evidencias y escenarios. Serie Observatorio Demográfico de América Latina y el Caribe, 2020. Santiago: CEPAL. 2021.

Li J, Huang DQ, Zou B, Yang H, Hui WZ, Rui F, et al. Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2021 Mar;93(3):1449-1458. doi: 10.1002/jmv.26424. Epub 2020 Aug 25.

Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021 Aug 21;21(1):855. doi: 10.1186/s12879-021-06536-3.

Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, Wooster L, Rotter JI, Guo X, Malhotra R. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. J Med Virol. 2020 Oct;92(10):1875-1883. doi: 10.1002/jmv.26050. Epub 2020 Jul 11.

Nash DM, Przech S, Wald R, O'Reilly D. Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit. J Crit Care. 2017 Oct; 41:138-144. doi: 10.1016/j.jcrc.2017.05.002. Epub 2017 May 9.

Chan KW, Yu KY, Lee PW, Lai KN, Tang SC. Global REnal Involvement of CORonavirus Disease 2019 (RECORD): A Systematic Review and Meta-Analysis of Incidence, Risk Factors, and Clinical Outcomes. Front Med (Lausanne). 2021 May 25; 8:678200. doi: 10.3389/fmed.2021.678200.

Published

2024-09-27

How to Cite

1.
Meneses-Liendo VH, Valencia Valz E. Mortality in COVID-19 patients with renal failure and need for dialysis. An evaluative review. Rev Méd Hered [Internet]. 2024 Sep. 27 [cited 2024 Oct. 7];35(3):149-56. Available from: http://44.198.254.164/index.php/RMH/article/view/5008

Issue

Section

ORIGINAL RESEARCH